These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9158807)

  • 1. Cases of Lyme borreliosis resistant to conventional treatment: improved symptoms with cephalosporin plus specific beta-lactamase inhibition.
    Gasser R; Reisinger E; Eber B; Pokan R; Seinost G; Berglöff J; Horwarth R; Sedaj B; Klein W
    Microb Drug Resist; 1995; 1(4):341-4. PubMed ID: 9158807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of late Lyme borreliosis with cefoperazone and sulbactam.
    Gasser RN; Reisinger EC; Eber B; Wendelin I; Pokan R; Seinost G; Klein W
    Lancet; 1995 Mar; 345(8949):586. PubMed ID: 7776796
    [No Abstract]   [Full Text] [Related]  

  • 3. Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.
    Li JT; Lu Y; Hou J; Chen YF; Miao JZ; Jia YX; Hou J; Zhang XZ; Chen DK; Hu WZ; Li LJ; Liu DM; Wang Z; Wu J; Gu JM; Wang HL; Zhang YL; Sun L
    Clin Infect Dis; 1997 Mar; 24(3):498-505. PubMed ID: 9114206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of sulbactam/cefoperazone in patients with respiratory infections in aged and/or with underlying respiratory diseases].
    Akutsu I; Motojima S; Sagara H; Ogata H; Otsuka T; Fukuda T; Ikemori R; Makino S
    Jpn J Antibiot; 1989 Apr; 42(4):910-20. PubMed ID: 2769942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India.
    Chandra A; Dhar P; Dharap S; Goel A; Gupta R; Hardikar JV; Kapoor VK; Mathur AK; Modi P; Narwaria M; Ramesh MK; Ramesh H; Sastry RA; Shah S; Virk S; Sudheer OV; Sreevathsa MR; Varshney S; Kochhar P; Somasundaram S; Desai C; Schou M
    Surg Infect (Larchmt); 2008 Jun; 9(3):367-76. PubMed ID: 18570578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
    Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR
    J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
    Fasola EL; Fasching CE; Peterson LR
    J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of combination therapy with sulbactam/cefoperazone and amikacin in the treatment of infectious diseases accompanied by hematological disorders].
    Matsushima T; Tamura K; Okamoto K; Kawada E; Murayama K; Maehara T; Sadakata H; Tamura J; Sawamura M; Morita K
    Jpn J Antibiot; 1993 Aug; 46(8):697-705. PubMed ID: 8230737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of cefoperazone/sulbactam in neonates.
    Ovali F; Gursoy T; Sari I; Divrikli D; Aktas A
    Pediatr Int; 2012 Feb; 54(1):60-3. PubMed ID: 21883691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical efficacy of sulbactam/cefoperazone for the treatment of geriatric patients with respiratory tract infections].
    Takaki K; Umeno M; Tanaka M; Harashima S; Takeda T; Okada K; Sawae Y
    Jpn J Antibiot; 1995 Jul; 48(7):942-8. PubMed ID: 7563587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A trial of using sulperazone (cefoperazone/sulbactam) in the combined treatment of patients with a burn infection].
    Iakovlev VP; Krutikov MG; Alekseev AA; Grishina IA; Izotova GN; Kashin IuD
    Antibiot Khimioter; 1995 May; 40(5):38-41. PubMed ID: 8534180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro assessment of sulbactam plus cefoperazone in the treatment of bacteria isolated from cancer patients.
    Bodey GP; Miller P; Ho DH
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):209S-214S. PubMed ID: 2591178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cefoperazone-sulbactam for treatment of severe melioidosis.
    Apisarnthanarak A; Little JR
    Clin Infect Dis; 2002 Mar; 34(5):721-3. PubMed ID: 11823963
    [No Abstract]   [Full Text] [Related]  

  • 14. Increase in the activity of third-generation cephalosporins in combination with clavulanic acid and Sulbactam against Bacteroides fragilis.
    Martín MA; Castillo AM; Liebana J; Mesa P; Piedrola G; Gutierrez J
    Med Lab Sci; 1990 Jul; 47(3):163-7. PubMed ID: 2402195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections.
    Patankar M; Sukumaran S; Chhibba A; Nayak U; Sequeira L
    J Assoc Physicians India; 2012 Nov; 60():22-4. PubMed ID: 23767198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized comparison of sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients.
    Winston DJ; Bartoni K; Bruckner DA; Schiller GJ; Territo MC
    Clin Infect Dis; 1998 Mar; 26(3):576-83. PubMed ID: 9524826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline.
    Feng J; Auwaerter PG; Zhang Y
    PLoS One; 2015; 10(3):e0117207. PubMed ID: 25806811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic effects of cefepime and sulbactam/cefoperazone on moderate and severe respiratory tract infection in children].
    Huang JJ; Zeng Q; Yu JL
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Sep; 25(9):1199-200. PubMed ID: 16174597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulbactam-containing beta-lactamase inhibitor combinations.
    Akova M
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():185-8. PubMed ID: 18154545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cefoperazone-sulbactam plus minocycline in the treatment of extensively drug resistant Acinetobacter infections].
    Shi Y; Xu YC; Liu Y; Du W; Rui X; Wang Y
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2847-50. PubMed ID: 23290215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.